PEDS 2021 Post-Event Survey Please let us know how the 2021 PEDS meeting went for you.What was/were your key takeaway(s) from the CureSearch PEDS?After attending CureSearch PEDS Sessions, do you have a better understanding about new approaches that can be implemented in clinical trial design for pediatric oncology? Yes No I’m not sure Are there learnings you’ll take back to your company/institution? Yes No I’m not sure In which session did you learn the most? Check all that apply. Expanding the Global Footprint Real-world Data and External Controls How do we find the “right” dose? Keynote, Elly Barry Clinical Trials with Combo Therapies Decentralized Clinical Trials Regulators Dish What did you most value about your participation? Check all that apply. Learnings from session topics Caliber of sessions and speakers Virtual meeting platform Virtual networking opportunities The event: Exceeded my expectations Met my expectations Was not what I expected Please briefly describe your selection.After your participation in the CureSearch PEDS, have you identified a way that you could engage with CureSearch to accelerate the pace of pediatric cancer drug development? Yes No I’m not sure If you answered yes, please describeAre you interested in participating in working groups and/or next steps that develop from discussions at the CureSearch PEDS? Yes No Are there other individuals or groups that should be included in the 2022 CureSearch Pediatric Early Development Symposium? If yes, and you can share, please list below.Is there additional feedback you would like to share?We welcome the chance to follow up on your unique feedback. Please share your contact information below (name and email). First Last Email The first two PEDS meetings have been virtual. If we could be in-person, would that be your preference? Yes, I would prefer to be in-person No, I prefer the virtual option I would like a hybrid option I do not have a preference Δ
